Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1

Experimental Cell Research

Volumn 303, Issue 2, 2005, Pages 240-251

  Tao, Yongguang ^a   Song, Xing ^a   Deng, Xiyun ^a   Xie, Daxin ^b   Lee, Leo M ^c   Liu, Yiping ^a   Li, Wei ^a   Li, Lili ^a   Deng, Lin ^a   Wu, Qiao ^d   Gong, Jianping ^b   Cao, Ya ^a  

^a Central South University   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c SAIC FREDERICK INC   (United States)

^d XIAMEN UNIVERSITY   (China)

Author keywords

CyclinE; CylinD1; Epidermal growth factor receptor; Epstein Bar virus; G1 S transition; Latent membrane protein 1; Nuclear accumulation

Indexed keywords

CYCLIN D1; CYCLIN E; EPIDERMAL GROWTH FACTOR RECEPTOR; LATENT MEMBRANE PROTEIN 1; ONCOPROTEIN;

ARTICLE; CARCINOMA CELL; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL NUCLEUS; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; NUCLEAR LOCALIZATION SIGNAL; PHASE TRANSITION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM;

HUMAN HERPESVIRUS 4;

EID: 19944433410     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2004.09.030     Document Type: Article

References (45)

1. A.B. Rickinson Epstein-Barr virus in action in vivo N. Engl. J. Med. 338 1998 1461 1463
2. S.T. Oh, J.S. Seo, U.Y. Moon, K.H. Kang, D.J. Shin, S.K. Yoon, W.H. Kim, J.G. Park, and S.K. Lee A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer Virology 320 2 2004, Mar. 15 330 336
3. A.J. Han, M. Xiong, and Y.S. Zong Association of Epstein-Barr virus with lymphoepithelioma-like carcinoma of the lung in southern China Am. J. Clin. Pathol. 114 2 2000, Aug. 220 226
4. M. Luftig, T. Yasui, V. Soni, M.S. Kang, N. Jacobson, E. Cahir-McFarland, B. Seed, and E. Kieff Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation Proc. Natl. Acad. Sci. U. S. A. 101 1 2004, Jan. 6 141 146
5. D.S. Huen, S.A. Henderson, D. Croom-Carter, and M. Rowe The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain Oncogene 10 1995 549 560
6. O. Devergne, E.D. Cahir McFarland, G. Mosialos, K.M. Izumi, C.F. Ware, and E. Kieff Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression J. Virol. 72 1998 7900 7908
7. A.G. Eliopoulos, and L.S. Young Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) Oncogene 16 1998 1731 1742
8. A.G. Eliopoulos, E.R. Waites, S.M. Blake, C. Davies, P. Murray, and L.S. Young TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40 J. Virol. 77 2003 1316 1328
9. O. Gires, F. Kohlhuber, E. Kilger, M. Baumann, A. Kieser, C. Kaiser, R. Zeidler, B. Scheffer, M. Ueffing, and W. Hammerschmidt Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins EMBO J. 18 1999 3064 3073
10. W.E. Miller, J.L. Cheshire, and N. Raab-Traub Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression Mol. Cell. Biol. 18 1998 2835 2844
11. P.J. Farrell Signal transduction from the Epstein-Barr virus LMP-1 transforming protein Trends Microbiol. 6 1998 175 178
12. N. Saito, G. Courtois, A. Chiba, N. Yamamoto, T. Nitta, and N. Hironaka Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell lines J. Biol. Chem. 278 2003 46565 46575
13. L. Deng, J. Yang, X.R. Zhao, X.Y. Deng, L. Zeng, and H.H. Gu Cells in G2/M phase increased in human nasopharyngeal carcinoma cell line by EBV-LMP1 through activation of NF-kappaB and AP-1 Cell Res. 13 2003 187 194
14. Y. Tao, X. Deng, Z. Hu, M. Tang, H. Gu, W. Yi, C. Wang, F. Luo, and Y. Cao EB virus encoded latent membrane protein 1 modulates the phosphorylation of epidermal growth factor receptor in nasopharyngeal carcinoma cell line Zhonghua Zhongliu Zazhi 24 3 2002, May 226 229
15. C. Wang, X. Deng, X. Li, H. Gu, W. Yi, X. Weng, L. Xia, and Y. Cao Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus LMP1 via NF-kappa B or AP-1 signaling pathway in nasopharyngeal carcinoma cells Zhonghua Zhongliu Zazhi 24 1 2002, Jan. 9 13
16. X.R. Zhao, H.H. Gu, X.X. Weng, W. Yi, X.Y. Deng, and Y. Cao The primary study on expression and function of D-type cyclins in nasopharyngeal carcinoma cell lines Shengwu Huaxue Yu Shengwu Wuli Xuebao (Shanghai) 32 2 2000 192 196
17. A.M. Mehl, J.E. Floettmann, M. Jones, P. Brennan, and M. Rowe Characterization of intercellular adhesion molecule-1 regulation by Epstein-Barr virus-encoded latent membrane protein-1 identifies pathways that cooperate with nuclear factor kappa B to activate transcription J. Biol. Chem. 276 2 2001, Jan. 12 984 992
18. E. Hatzivassiliou, and G. Mosialos Cellular signaling pathways engaged by the Epstein-Barr virus transforming protein LMP1 Front Biosci. 7 2002, Jan. 1 d319 d329
19. A. Wells, and U. Marti Signalling shortcuts: cell-surface receptors in the nucleus? Nat. Rev., Mol. Cell Biol. 3 2002 697 702
20. M. Offterdinger, C. Schofer, K. Weipoltshammer, and T.W. Grunt c-erbB-3: a nuclear protein in mammary epidermal cells J. Cell Biol. 157 2002 929 939
21. H.J. Lee, K.M. Jung, and Y.Z. Huang Presenilin-dependent gamma-secretase-like intramembrane cleavage of ErbB4 J. Biol. Chem. 277 2002 6318 6323
22. S.Y. Lin, K. Makino, and W. Xia Nuclear localization of EGF receptor and its potential new role as a transcription factor Nat. Cell Biol. 3 2001 802 808
23. T. Kobayashi, K. Hashimoto, H. Okumura, H. Asada, and K. Yoshikawa Endogenous EGF-family growth factors are necessary for the progression from the G1 to S phase in human keratinocytes J. Invest. Dermatol. 111 4 1998, Oct. 616 620
24. N. Takuwa, and Y. Takuwa Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts Mol. Cell. Biol. 17 9 1997, Sep. 5348 5358
25. J. Blenis Signal transduction via the MAP kinases: proceed at your own RSK Proc. Natl. Acad. Sci. U. S. A. 90 13 1993, Jul. 1 5889 5892
26. M. Malumbres, and A. Pellicer RAS pathways to cell cycle control and cell transformation Front Biosci. 3 1998, Aug. 6 d887 d912
27. M. Kawada, S. Yamagoe, Y. Murakami, K. Suzuki, S. Mizuno, and Y. Uehara Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway Oncogene 15 6 1997, Aug. 7 629 637
28. D. Busse, R.S. Doughty, T.T. Ramsey, W.E. Russell, J.O. Price, W.M. Flanagan, L.K. Shawver, and C.L. Arteaga Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity J. Biol. Chem. 275 10 2000, Mar. 10 6987 6995
29. C. Santiskulvong, J. Sinnett-Smith, and E. Rozengurt EGF receptor function is required in late G(1) for cell cycle progression induced by bombesin and bradykinin Am. J. Physiol.: Cell Physiol. 281 3 2001, Sep. C886 C898
30. N.E. Baker, and S.Y. Yu The EGF receptor defines domains of cell cycle progression and survival to regulate cell number in the developing Drosophila eye Cell 104 5 2001, Mar. 9 699 708
31. W. Liao, H. Yi, X.Y. Li, M. Tang, H.H. Gu, and Y. Cao Doxycycline dependent expression of Epstein-Barr virus latent membrane protein 1 with tet regulating system in nasopharygeal carcinoma cell line Shengwu Huaxue Yu Shengwu Wuli Xuebao (Shanghai) 31 3 1999 309 312
32. E.A. Nigg Nucleocytoplasmic transport: signals, mechanisms and regulation Nature 386 1997 779 787
33. A. Kaffman, N.M. Rank, and E.M. O'Neill The receptor Msn5 exports the phosphorylated transcription factor Pho4 out of the nucleus Nature 396 1998 482 486
34. R. Ben-Levy, S. Hooper, and R. Wilson Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2 Curr. Biol. 8 1998 1049 1057
35. C. Wang, X. Li, and H. Gu Increase of EGFR expression by Epstein-Barr virus LMP1 in nasopharyngeal carcinoma cells Zhonghua Zhongliu Zazhi 23 4 2001, Jul. 269 272
36. C.Y. Ni, M.P. Murphy, and T.E. Golde Carpenter G. gamma-secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase Science 294 5549 2001, Dec. 7 2179 2181
37. R. Srinivasan, C.E. Gillett, D.M. Barnes, and W.J. Gullick Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers Cancer Res. 60 6 2000, Mar. 15 1483 1487
38. J.B. Cordero, M. Cozzolino, and Y. Lu 1,25-Dihydroxyvitamin D down-regulates cell membrane growth- and nuclear growth-promoting signals by the epidermal growth factor receptor J. Biol. Chem. 277 2002 38965 38971
39. J.F. Reilly, and P.A. Maher Importin beta-mediated nuclear import of fibroblast growth factor receptor: role in cell proliferation J. Cell Biol. 152 6 2001 1307 1312
40. H. Peng, J. Moffett, J. Myers, X. Fang, E.K. Stachowiak, P. Maher, E. Kratz, J. Hines, S.J. Fluharty, E. Mizukoshi, D.C. Bloom, and M.K. Stachowiak Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors Mol. Biol. Cell 12 2 2001, Feb. 449 462
41. M. Srivastava, and H.B. Pollard Molecular dissection of nucleolin's role in growth and cell proliferation: new insights FASEB J. 13 14 1999, Nov. 1911 1922
42. H. Ginisty, H. Sicard, B. Roger, and P. Bouvet Structure and functions of nucleolin J. Cell Sci. 112 Pt. 6 1999, Mar. 761 772
43. N. Fujita, Y. Furukawa, N. Itabashi, Y. Tsuboi, M. Matsuda, K. Okada, and T. Saito Failure of cdc2 promoter activation and G(2)/M transition by ANG II and AVP in vascular smooth muscle cells Am. J. Physiol. 277 2 Pt. 2 1999, Aug. H515 H523
44. Y. Furukawa, S. Iwase, J. Kikuchi, Y. Terui, M. Nakamura, H. Yamada, Y. Kano, and M. Matsuda Phosphorylation of Bcl-2 protein by CDC2 kinase during G2/M phases and its role in cell cycle regulation J. Biol. Chem. 275 28 2000, Jul. 14 21661 21667
45. O. Planz, S. Pleschka, K. Oesterle, F. Berberich-Siebelt, C. Ehrhardt, L. Stitz, and S. Ludwig Borna disease virus nucleoprotein interacts with the CDC2-cyclin B1 complex J. Virol. 77 20 2003, Oct. 11186 11192